Total Payments
$2,948
2022 Payments
$372.71
Companies
33
Transactions
156
Medicare Patients
782
Medicare Billing
$76,339
Payment Breakdown by Category
Food & Beverage$2,823 (95.8%)
Education$106.80 (3.6%)
Other$18.32 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,823 | 153 | 95.8% |
| Education | $106.80 | 2 | 3.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18.32 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $686.46 | 57 | $0 (2022) |
| Amgen Inc. | $597.03 | 13 | $0 (2022) |
| Allergan, Inc. | $310.85 | 15 | $0 (2021) |
| GENZYME CORPORATION | $125.34 | 6 | $0 (2022) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $116.26 | 7 | $0 (2021) |
| ABBVIE INC. | $103.85 | 6 | $0 (2022) |
| Genentech USA, Inc. | $89.08 | 5 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $83.05 | 4 | $0 (2022) |
| LivaNova USA, Inc. | $79.89 | 4 | $0 (2020) |
| Lundbeck LLC | $71.23 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $372.71 | 15 | Biogen, Inc. ($95.36) |
| 2021 | $521.27 | 32 | Biogen, Inc. ($189.79) |
| 2020 | $377.40 | 26 | Biogen, Inc. ($114.81) |
| 2019 | $469.67 | 22 | Allergan Inc. ($126.79) |
| 2018 | $810.47 | 28 | Amgen Inc. ($434.58) |
| 2017 | $396.25 | 33 | Biogen, Inc. ($160.23) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/29/2022 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: Neurology | ||||||
| 06/29/2022 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Rare Disease | ||||||
| 06/23/2022 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Migraine | ||||||
| 06/01/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $39.89 | General |
| Category: Neuroscience | ||||||
| 05/26/2022 | Janssen Pharmaceuticals, Inc | Ponvory (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Neuroscience | ||||||
| 05/24/2022 | GENZYME CORPORATION | AUBAGIO (Drug) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Neurology | ||||||
| 04/14/2022 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $26.39 | General |
| Category: NEUROLOGY | ||||||
| 04/06/2022 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Rare Disease | ||||||
| 03/30/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $32.41 | General |
| Category: Neurology | ||||||
| 03/16/2022 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.47 | General |
| Category: Neuroscience | ||||||
| 03/02/2022 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: NEUROSCIENCE | ||||||
| 01/26/2022 | Biogen, Inc. | AVONEX (Biological), PLEGRIDY, VUMERITY | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: Neurology | ||||||
| 01/19/2022 | Biogen, Inc. | ADUHELM (Biological) | Food and Beverage | In-kind items and services | $29.27 | General |
| Category: Neurology | ||||||
| 01/05/2022 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Neurology | ||||||
| 12/09/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Neuroscience | ||||||
| 12/07/2021 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: NEUROLOGY | ||||||
| 12/07/2021 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $1.07 | General |
| Category: NEUROLOGY | ||||||
| 12/02/2021 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.88 | General |
| Category: NEUROLOGY | ||||||
| 11/16/2021 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: NEUROLOGY | ||||||
| 10/27/2021 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $21.38 | General |
| 10/19/2021 | Biogen, Inc. | TYSABRI (Biological) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: NEUROLOGY | ||||||
| 10/05/2021 | Janssen Pharmaceuticals, Inc | — | Food and Beverage | In-kind items and services | $33.48 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 61 | 78 | $9,710 | $3,560 |
| 2022 | 3 | 177 | 226 | $38,134 | $15,566 |
| 2021 | 5 | 237 | 348 | $55,139 | $27,689 |
| 2020 | 5 | 307 | 430 | $69,904 | $29,524 |
Total Patients
782
Total Services
1,082
Medicare Billing
$76,339
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 37 | 54 | $5,135 | $1,922 | 37.4% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 11 | 11 | $2,425 | $828.20 | 34.2% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 13 | 13 | $2,151 | $810.16 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 75 | 110 | $20,473 | $8,106 | 39.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 34 | 36 | $7,085 | $2,716 | 38.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 21 | 28 | $3,861 | $2,155 | 55.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 35 | 40 | $5,106 | $1,965 | 38.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 12 | 12 | $1,609 | $623.51 | 38.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 86 | 144 | $26,208 | $12,804 | 48.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 89 | 130 | $16,120 | $7,754 | 48.1% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 37 | 49 | $6,757 | $4,088 | 60.5% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2021 | 12 | 12 | $3,593 | $1,845 | 51.3% |
| 95908 | Nerve transmission studies, 3-4 studies | Office | 2021 | 13 | 13 | $2,461 | $1,196 | 48.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 127 | 177 | $32,214 | $12,772 | 39.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 100 | 148 | $18,352 | $6,891 | 37.5% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 43 | 66 | $9,101 | $5,082 | 55.8% |
| 95910 | Nerve transmission studies, 7-8 studies | Office | 2020 | 18 | 19 | $5,689 | $2,980 | 52.4% |
| 95909 | Nerve transmission studies, 5-6 studies | Office | 2020 | 19 | 20 | $4,548 | $1,799 | 39.5% |
About Dr. Gilbert Snider, M.D
Dr. Gilbert Snider, M.D is a Specialist healthcare provider based in Chesapeake, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1588663751.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gilbert Snider, M.D has received a total of $2,948 in payments from pharmaceutical and medical device companies, with $372.71 received in 2022. These payments were reported across 156 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($2,823).
As a Medicare-enrolled provider, Snider has provided services to 782 Medicare beneficiaries, totaling 1,082 services with total Medicare billing of $76,339. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Chesapeake, VA
- Active Since 07/19/2005
- Last Updated 11/19/2020
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1588663751
Products in Payments
- Aimovig (Biological) $439.42
- TECFIDERA (Drug) $246.79
- TYSABRI (Biological) $214.39
- VUMERITY (Drug) $152.43
- AUBAGIO (Drug) $125.34
- BOTOX (Biological) $114.34
- ZEPOSIA (Drug) $97.94
- BOTOX COSMETIC (Biological) $91.00
- OCREVUS (Biological) $89.08
- VNS Therapy (Device) $79.89
- VYEPTI (Biological) $71.23
- BOTOX THERAPEUTIC (Biological) $66.09
- GILENYA (Drug) $48.65
- QULIPTA (Drug) $46.96
- ADUHELM (Biological) $46.80
- ACTIVA (Device) $46.31
- INGREZZA (Drug) $39.81
- UBRELVY (Drug) $39.42
- NUPLAZID (Drug) $37.76
- KESIMPTA (Drug) $34.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Chesapeake
Neil Pugach, M.d, M.D
Specialist — Payments: $332,896
Specialist $332,896
Dr. Jon Adleberg, M.d, M.D
Specialist — Payments: $34,587
Specialist $34,587
Dr. David Goss, M.d, M.D
Specialist — Payments: $18,099
Specialist $18,099
Mrs. Patricia King, M.d, M.D
Specialist — Payments: $13,267
Specialist $13,267
Stephanie Marioneaux, M.d, M.D
Specialist — Payments: $6,855
Specialist $6,855
Idalia Rosado-Torres, M.d, M.D
Specialist — Payments: $5,321
Specialist $5,321